Clinical Trials
35
Active:2
Completed:9
Trial Phases
4 Phases
Phase 1:4
Phase 2:6
Phase 3:20
+1 more phases
Drug Approvals
5
NMPA:3
SFDA:2
Drug Approvals
Clinical Trials
Distribution across different clinical trial phases (32 trials with phase data)• Click on a phase to view related trials
Phase 3
20 (62.5%)Phase 2
6 (18.8%)Phase 1
4 (12.5%)Not Applicable
1 (3.1%)phase_1_2
1 (3.1%)To Assess the Effect of the Special Condition on the Pharmacokinetics and Tolerability of the Esflurbiprofen Topical System (EFTS) in Healthy Volunteers.
Phase 1
Completed
- Conditions
- Healthy
- Interventions
- Drug: Esflurbiprofen Topical System
- First Posted Date
- 2025-03-11
- Last Posted Date
- 2025-04-22
- Lead Sponsor
- Teikoku Seiyaku Co., Ltd.
- Target Recruit Count
- 28
- Registration Number
- NCT06870422
- Locations
- 🇩🇪
SocraTec R&D GmbH Clinical Pharmacology Unit, Mainzerhofplatz, Erfurt, Germany
Phase III Trial to Assess the Safety and Efficacy of TK-254RX in Patients With Contusions
Phase 3
Recruiting
- Conditions
- Contusions
- Interventions
- Drug: Esflurbiprofen Topical System (EFTS)
- First Posted Date
- 2025-03-11
- Last Posted Date
- 2025-04-18
- Lead Sponsor
- Teikoku Seiyaku Co., Ltd.
- Target Recruit Count
- 219
- Registration Number
- NCT06871046
- Locations
- 🇩🇪
Medical Practice Ebert, Siemensstr, Bonn, Germany
🇩🇪Medical Practice Prof. Predel, Siemensstr, Bonn, Germany
🇩🇪Medical Practice Schaale-Maas, Siemensstr, Bonn, Germany
Phase III Trial to Evaluate the Efficacy and Safety in Patients With Ankle Sprains.
Phase 3
Recruiting
- Conditions
- Ankle Sprains
- Interventions
- Drug: Esflurbiprofen Topical System (EFTS)Drug: Placebo Patch
- First Posted Date
- 2025-03-10
- Last Posted Date
- 2025-09-09
- Lead Sponsor
- Teikoku Seiyaku Co., Ltd.
- Target Recruit Count
- 69
- Registration Number
- NCT06866613
- Locations
- 🇩🇪
Medical Practice Ebert, Siemensstr, Bonn, Germany
🇩🇪Medical Practice Prof. Predel, Siemensstr, Bonn, Germany
🇩🇪Medical Practice Schaale-Maas, Siemensstr, Bonn, Germany
To Assess the Bioavailability of TK-254RX in Comparison with Oral Flurbiprofen Tablets and the Adhesion of TK-254RX in Healthy Subjects
Phase 1
Completed
- Conditions
- Healthy
- Interventions
- Drug: Esflurbiprofen Topical SystemDrug: Flurbiprofen tablet
- First Posted Date
- 2025-02-12
- Last Posted Date
- 2025-03-11
- Lead Sponsor
- Teikoku Seiyaku Co., Ltd.
- Target Recruit Count
- 26
- Registration Number
- NCT06823284
- Locations
- 🇩🇪
SocraTec R&D GmbH Clinical Pharmacology Unit, Mainzerhofplatz 14, Erfurt, Germany
Open Label Trial to Evaluate the Adhesion of TK-254RX in Healthy Volunteers.
- First Posted Date
- 2023-09-18
- Last Posted Date
- 2024-04-12
- Lead Sponsor
- Teikoku Seiyaku Co., Ltd.
- Target Recruit Count
- 80
- Registration Number
- NCT06042192
- Locations
- 🇩🇪
Medical Practice Ebert, Brühl, Germany
🇩🇪Medical practice Pabst, Fürstenfeldbruck, Germany
🇩🇪Medical practice Gastl, Gilching, Germany
- Prev
- 1
- 2
- Next
News
No news found